Penequinine, Penehyclidine is under investigation in clinical trial NCT02644876 (Preventive Effects of Penehyclidine Hydrochloride Inhalation on Postoperative Pulmonary Complications).
⑴麻醉前给药以抑制涎腺和气道腺体分泌。
⑵用于有机磷毒物中毒急救治疗和中毒后期或胆碱酯酶老化后维持阿托品化。但单独应用疗效差,应与酶重活化剂联合应用。
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.